How Autoimmune Diseases Turn the Body's Defenses Against Itself

When the Immune System Turns Inward

The human immune system is capable of recognizing and destroying millions of foreign pathogens while leaving the body's own 37 trillion cells untouched. This precision is achieved through a process called immune tolerance — a series of molecular checkpoints that eliminate or suppress immune cells capable of attacking self-tissues. When tolerance fails, the result is autoimmune disease. More than 80 distinct autoimmune conditions have been identified, collectively affecting an estimated 5–8% of the global population. Women are disproportionately affected, accounting for approximately 78% of all autoimmune disease cases, a disparity researchers link to sex hormone effects on immune regulation.

The Foundation: Self-Tolerance in the Thymus

T cells — the lymphocytes that orchestrate adaptive immune responses — undergo a critical education in the thymus gland. The process, called negative selection, eliminates T cells that recognize self-antigens. Medullary thymic epithelial cells express a transcription factor called AIRE (autoimmune regulator), which causes them to display proteins from virtually every tissue in the body — including insulin from the pancreas, myelin from neurons, and collagen from joints. T cells that react strongly to these self-peptides are deleted via apoptosis. This ensures that potentially self-reactive T cells are removed before they enter circulation.

Negative selection is imperfect. Some self-reactive T cells escape. A second layer of peripheral tolerance — including regulatory T cells (Tregs), inhibitory checkpoints like CTLA-4, and the requirement for co-stimulatory signals — prevents escaped self-reactive cells from becoming activated under normal conditions.

How Tolerance Breaks Down

Three major mechanisms are recognized in the breakdown of immune tolerance:

Molecular Mimicry

Certain pathogens carry antigens that closely resemble host proteins. When the immune system mounts a response against the pathogen, some of the antibodies or T cells generated also recognize self-antigens. Group A Streptococcus infection, for example, triggers antibodies that cross-react with cardiac muscle proteins, causing rheumatic fever and rheumatic heart disease. Campylobacter jejuni infection precedes approximately 40% of cases of Guillain-Barré syndrome, in which antibodies against bacterial lipopolysaccharide cross-react with gangliosides in peripheral nerve myelin.

Bystander Activation

During severe infections, massive local inflammation releases cytokines that can non-specifically activate self-reactive T cells that would otherwise remain dormant. These cells do not require normal antigen-specific activation — the inflammatory environment lowers their activation threshold sufficiently to trigger a response.

Epitope Spreading

Once tissue is damaged — by infection, bystander activation, or initial autoimmune attack — intracellular proteins normally hidden from the immune system are released. The immune system encounters these new antigens and mounts additional responses, progressively broadening the autoimmune attack to more tissue components. This explains why autoimmune diseases tend to worsen over time and why many patients develop multiple overlapping conditions.

Common Autoimmune Diseases and Their Targets

The Role of Genetics and Environment

Autoimmune diseases are not caused by a single gene mutation. They arise from the convergence of genetic susceptibility — primarily in HLA (human leukocyte antigen) genes on chromosome 6 — and environmental triggers. HLA molecules present peptides to T cells; variants that present self-peptides more effectively are strongly associated with specific autoimmune diseases. HLA-DR4 increases RA risk 4-fold; HLA-DQ2 and DQ8 are present in nearly all celiac disease patients.

• Smoking: dramatically increases RA risk in genetically susceptible individuals by promoting citrullination of proteins — a modification that makes them antigenic
• Gut microbiome: dysbiosis (imbalance in gut bacteria) is associated with multiple autoimmune diseases; germ-free animal models rarely develop spontaneous autoimmunity
• Vitamin D deficiency: epidemiological studies link low vitamin D levels with higher rates of MS, RA, and lupus
• Epstein-Barr virus (EBV): infection is virtually universal in MS patients; a 2022 study in Science by Bjornevik et al., analyzing 10 million U.S. military personnel records, found EBV infection increased MS risk 32-fold

Diagnosis and Autoantibody Testing

Diagnosing autoimmune diseases requires combining clinical features, laboratory markers, and sometimes biopsy. Autoantibody tests detect immunoglobulins that target specific self-proteins. While useful, they are not perfectly specific — antinuclear antibodies (ANA), a screening test for lupus, are positive in up to 25% of healthy individuals at low titers.

• Inflammatory markers (CRP, ESR) indicate active inflammation but are nonspecific
• Complement levels (C3, C4) fall in active lupus nephritis as complement is consumed by immune complexes
• Synovial fluid analysis, skin biopsy, and nerve conduction studies may be required for specific diagnoses

Treatment Strategies

This article is for informational purposes only. Consult a qualified healthcare professional for medical advice.